StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) income statement

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$29.68−1.75 (-5.58%)

Close on Nov 18, 2026Market cap $992.74MP/E –Yield –

SpyGlass Pharma, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
50.1%

Financial strength

Current ratio
25.06
Debt to equity
–
Debt to assets
–
Cash to current liabilities
2364.6%

Valuation

P/E ratio
–
Price to sales
–
Price to book
4.27
Dividend yield
–

See a number that looks wrong?